Vident Investment Advisory’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,621
| Closed | -$398K | – | 1304 |
|
|
2023
Q1 | $398K | Buy |
6,621
+1,911
| +41% | +$115K | 0.01% | 858 |
|
|
2022
Q4 | $345K | Buy |
4,710
+1,115
| +31% | +$81.8K | 0.01% | 835 |
|
|
2022
Q3 | $270K | Buy |
+3,595
| New | +$270K | 0.01% | 923 |
|
|
2022
Q1 | – | Sell |
-4,546
| Closed | -$341K | – | 1325 |
|
|
2021
Q4 | $341K | Buy |
4,546
+1,844
| +68% | +$138K | 0.01% | 1028 |
|
|
2021
Q3 | $314K | Buy |
2,702
+1,133
| +72% | +$132K | 0.01% | 993 |
|
|
2021
Q2 | $348K | Sell |
1,569
-824
| -34% | -$183K | 0.01% | 915 |
|
|
2021
Q1 | $316K | Sell |
2,393
-149
| -6% | -$19.7K | 0.01% | 904 |
|
|
2020
Q4 | $440K | Buy |
+2,542
| New | +$440K | 0.02% | 754 |
|